Insider · CIK 0001307632
Richard J Hawkins
Files at CNSY (CERENOME, INC.), LUMOS PHARMA, INC., SVRA (Savara Inc). First filing Dec 16, 2024, latest Dec 16, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SVRA: Savara Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Savara Inc | $27k 8,000 shares | -11% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CNSY CERENOME, INC. | MOption exercise Common Stock | +921 | $0.00 | $0 | 2,450 | 11 d ago |
| Oct 1, 2026 | CNSY CERENOME, INC. | MOption exercise Restricted Stock Unitsderivative | -921 | $0.00 | $0 | 1,843 | 11 d ago |
| Feb 18, 2025 | CNSY CERENOME, INC. | AGrant or award Stock Option (Right to Buy)derivative | +40,122 | $0.00 | $0 | 40,122 | Feb 20, 2025 |
| Dec 12, 2024 | SVRA Savara Inc | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 75,241 | Dec 16, 2024 |
| Dec 16, 2024 | SVRA Savara Inc | SOpen-market sale Common Stock | -8,000 | $3.32 | $27k | 67,241 | Dec 16, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Common Stock | -753,093 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Common Stockindirect: By Charitable Trust | -4,469 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,624 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,400 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,400 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -135,000 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,400 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -28,475 | - | - | 0 | Dec 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.